These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 810319)

  • 21. [1st results in the treatment of schizophrenic syndromes using sulpiride].
    Colucci D'Amato C; Luciano LR
    Acta Neurol (Napoli); 1973; 28(6):714-29. PubMed ID: 4593209
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial.
    Lepola U; Koskinen T; Rimón R; Salo H; Gordin A
    Acta Psychiatr Scand; 1989 Jul; 80(1):92-6. PubMed ID: 2669445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long- and short-term effects of sulpiride on sleep-EEG of man].
    Schneider E; Ziegler B; Maxion H; Badawi M
    Arzneimittelforschung; 1974 Jul; 24(7):990-3. PubMed ID: 4368177
    [No Abstract]   [Full Text] [Related]  

  • 24. Loxapine succinate: a controlled double-blind study in schizophrenia.
    Charalampous KD; Freemesser GF; Malev J; Ford K
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):829-37. PubMed ID: 4217251
    [No Abstract]   [Full Text] [Related]  

  • 25. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
    Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
    Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971 Dec; 3(9):6-13. PubMed ID: 4948869
    [No Abstract]   [Full Text] [Related]  

  • 27. [Importance of trifluoperazine in the process of social readaptation in cases of chronic schizophrenia].
    Cieślik Z; Leczycka K; Thille Z; Trembla K
    Psychiatr Pol; 1969; 3(3):333-9. PubMed ID: 4896422
    [No Abstract]   [Full Text] [Related]  

  • 28. A single-blind study of clocapramine and sulpiride in hospitalized chronic schizophrenic patients.
    Yamagami S; Kiriike N; Kawaguchi K
    Drugs Exp Clin Res; 1988; 14(11):707-13. PubMed ID: 3246215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of aqueous pineal extract in chronic schizophrenia.
    Bigelow LB
    Biol Psychiatry; 1974 Feb; 8(1):5-15. PubMed ID: 4592789
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical studies with sulpiride in schizophrenics hospitalized for many years].
    Eckmann F
    Agressologie; 1978; 19(C):153-6. PubMed ID: 375761
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypertensive episodes initiated by sulpiride (Dogmatil)].
    Corvol P; Bisseliches F; Alexandre JM; Bohuon C; Heurtault JP; Ménard J; Tcherdakoff P; Vaysse JC; Milliez P
    Ann Med Interne (Paris); 1973; 124(8):647-9. PubMed ID: 4588186
    [No Abstract]   [Full Text] [Related]  

  • 32. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
    Gendron JL; Zimmermann RL; Schiele BC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 34. A transcultural study with clomacran: comparison of two assessment methods.
    Ban TA; Lehmann HE; Galvan L; Pecknold JC; Climan M
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):971-89. PubMed ID: 4214672
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of the Middlesex Hospital Questionnaire (MHQ) in the psychosomatic field. Personal contribution].
    Caponeri MA; Cicchetti V
    Clin Ter; 1978 Oct; 87(1):51-67. PubMed ID: 367687
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sulpiride, autism and course under MMPI].
    Collard J; Fraipont J; Dufrasne M
    Lille Med; 1972 Jan; 17():Suppl 1:33-6. PubMed ID: 4402108
    [No Abstract]   [Full Text] [Related]  

  • 37. [Three antipsychotic drugs in the treatment of schizophrenia--a controlled and double-blind study].
    Yang WJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):277-80, 318-9. PubMed ID: 3069383
    [No Abstract]   [Full Text] [Related]  

  • 38. Haloperidol--new addition to the drug treatment of schizophrenia.
    Stewart A; Lafave HG; Segovia G
    Behav Neuropsychiatry; 1969 Oct; 1(7):23-8. PubMed ID: 4907607
    [No Abstract]   [Full Text] [Related]  

  • 39. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
    Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601
    [No Abstract]   [Full Text] [Related]  

  • 40. A clinical trial of an antiserotonin compound, cinanserin, in chronic schizophrenia.
    Holden JM; Keskiner A; Gannon P
    J Clin Pharmacol New Drugs; 1971; 11(3):220-6. PubMed ID: 4946100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.